Literature DB >> 19765366

Serotonin and the GI tract.

William L Hasler1.   

Abstract

Serotonin (5-hydroxytryptamine, 5-HT) participates in several functions of the gastrointestinal tract. Receptors in seven families (5-HT(1)-5-HT(7)) were identified, many of which are present on enterocytes, intrinsic and extrinsic neurons, interstitial cells, and gut myocytes. Most 5-HT is released from enterochromaffin cells in response to physiologic and pathologic stimuli. Roles of 5-HT in health include control of normal gut motor activity, secretion, and sensation, and regulation of food intake and cell growth. Abnormalities of serotonergic function contribute to symptom genesis in functional bowel disorders, inflammatory and infectious diseases of the gut, emetic responses to varied stimuli, obesity, and dysregulation of cell growth. Therapies acting as agonists or antagonists of 5-HT receptors or that modulate 5-HT reuptake play prominent roles in managing these conditions, although use of many agents is hampered by cardiopulmonary complications. Novel agents are in testing, which may exhibit efficacy without significant toxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765366     DOI: 10.1007/s11894-009-0058-7

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  48 in total

1.  Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease.

Authors:  Nicholas S Coleman; Stephen Foley; Simon P Dunlop; Johanna Wheatcroft; Elaine Blackshaw; Alan C Perkins; Gulzar Singh; Charles A Marsden; Geoffrey K Holmes; Robin C Spiller
Journal:  Clin Gastroenterol Hepatol       Date:  2006-06-22       Impact factor: 11.382

2.  Use of antidepressants and risk of colorectal cancer: a nested case-control study.

Authors:  Wanning Xu; Hani Tamim; Stan Shapiro; Mary Rose Stang; Jean-Paul Collet
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

3.  Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.

Authors:  J J Chen; Z Li; H Pan; D L Murphy; H Tamir; H Koepsell; M D Gershon
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

4.  Impaired gastrocolonic response and peristaltic reflex in slow-transit constipation: role of 5-HT(3) pathways.

Authors:  Einar S Björnsson; William D Chey; Forrest Hooper; Michelle L Woods; Chung Owyang; William L Hasler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-08       Impact factor: 4.052

5.  Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan.

Authors:  Louis P Vera-Portocarrero; Michael H Ossipov; Tamara King; Frank Porreca
Journal:  Gastroenterology       Date:  2008-07-03       Impact factor: 22.682

6.  Serotonin signaling in diverticular disease.

Authors:  Meagan M Costedio; Matthew D Coates; Amy B Danielson; Thomas R Buttolph; Hagen J Blaszyk; Gary M Mawe; Neil H Hyman
Journal:  J Gastrointest Surg       Date:  2008-05-20       Impact factor: 3.452

7.  Identification of patients with non-d, non-C irritable bowel syndrome and treatment with renzapride: an exploratory, multicenter, randomized, double-blind, placebo-controlled clinical trial.

Authors:  R C Spiller; N L Meyers; R I Hickling
Journal:  Dig Dis Sci       Date:  2008-05-10       Impact factor: 3.199

Review 8.  5-HT4 receptor agonists: similar but not the same.

Authors:  J H De Maeyer; R A Lefebvre; J A J Schuurkes
Journal:  Neurogastroenterol Motil       Date:  2008-02       Impact factor: 3.598

Review 9.  Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Viola Andresen; Victor M Montori; Jutta Keller; Colin P West; Peter Layer; Michael Camilleri
Journal:  Clin Gastroenterol Hepatol       Date:  2008-01-31       Impact factor: 11.382

10.  A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew.

Authors:  Nissar A Darmani; Jennifer L Crim; Jano J Janoyan; Joseph Abad; Juan Ramirez
Journal:  Brain Res       Date:  2008-11-06       Impact factor: 3.252

View more
  16 in total

Review 1.  Classification and functions of enteroendocrine cells of the lower gastrointestinal tract.

Authors:  Ashok R Gunawardene; Bernard M Corfe; Carolyn A Staton
Journal:  Int J Exp Pathol       Date:  2011-04-25       Impact factor: 1.925

2.  Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis.

Authors:  Kellie Simmons; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2014-03-11       Impact factor: 3.199

3.  Adynamic ileus and diarrhoea: a rare adverse effect of antidepressants.

Authors:  Filipa T Carreiro; Susana Carvalho Coelho; Alexandra Bayão Horta; João Sá
Journal:  BMJ Case Rep       Date:  2015-05-29

Review 4.  Gastroparesis: Medical and Therapeutic Advances.

Authors:  Christopher M Navas; Nihal K Patel; Brian E Lacy
Journal:  Dig Dis Sci       Date:  2017-07-18       Impact factor: 3.199

Review 5.  Recent advances in pharmacological treatment of irritable bowel syndrome.

Authors:  Georgia Lazaraki; Grigoris Chatzimavroudis; Panagiotis Katsinelos
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

6.  Lubiprostone targets prostanoid signaling and promotes ion transporter trafficking, mucus exocytosis, and contractility.

Authors:  Robert L Jakab; Anne M Collaco; Nadia A Ameen
Journal:  Dig Dis Sci       Date:  2012-08-25       Impact factor: 3.199

7.  Regulation of intestinal serotonin transporter expression via epigenetic mechanisms: role of HDAC2.

Authors:  Ravinder K Gill; Anoop Kumar; Pooja Malhotra; Daniel Maher; Varsha Singh; Pradeep K Dudeja; Waddah Alrefai; Seema Saksena
Journal:  Am J Physiol Cell Physiol       Date:  2012-11-28       Impact factor: 4.249

8.  Colonic migrating motor complexes, high amplitude propagating contractions, neural reflexes and the importance of neuronal and mucosal serotonin.

Authors:  Terence K Smith; Kyu Joo Park; Grant W Hennig
Journal:  J Neurogastroenterol Motil       Date:  2014-10-30       Impact factor: 4.924

9.  Symptomatic Improvement of Gastroparesis with Granisetron Transdermal System.

Authors:  Hye-Kyung Jung
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

10.  Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study.

Authors:  Deena Midani; Henry P Parkman
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.